Labroots is happy to announce that registration is open for the 5th Annual Event in the Bioprocessing Virtual Event Series, which will be held online only on April 5, 2023. This fantastic event is free to attend and will feature speakers from both academia and industry to discuss new opportunities, key challenges, and recent successes in the current bioprocessing landscape. Participation in the event will also earn attendees free continuing education (CE) credits, as well.
"Gene therapy-based medicines have opened new doors for the treatment and cure of genetic diseases. However, a generic manufacturing platform for gene therapy products has yet to be developed. Information sharing via Labroots' platform will be critical as we shape the future for how therapeutics are made," said Baley Reeves, PhD, Interim Director, National Center for Therapeutics Manufacturing, Texas A&M Engineering
"I will present data about a pioneering expression system developed by my group at the University of Kent that improves yield, speed and efficiencies in the biotechnology industry to create proteins in bacteria," said Dan Mulvihill, PhD, Professor, Cell and Molecular Biology at the University of Kent. "This new technology enables scientists to reprogram a cell to direct the packaging of specific molecules into a separate structure, known as a vesicle, which is then exported out of the cell. This patented technology will improve efficiencies in creating and storing recombinant proteins, which have a range of uses from antibodies to energy production, and I'm delighted to share this technology via Labroots' unique platform."
Topics for this year’s event include:
Drug Discovery & Preclinical Development
Characterization of Novel Biotherapeutics
High Throughput Methods in Discovery
Non-Animal Methods for Early Characterization
Upstream Processing
Cell Culture Optimization and Cell Line Development
Microbial Processes Development and Optimization
Emerging Expression Systems
Perfusion vs. Batch Operation for Cell Culture
Modeling and Simulation
Downstream Processing
Detection and Characterization of Impurities in Biologics
Continuous Processing
Advances in Purification Unit Operations
Advances in Nonchromatographic Purifications
Analytical & Quality
Rapid Methods to Access Quality and Stability of Biologics
Online Process Monitoring
Real-time QA/QC for Rapid Release
PAT Implementation for Process Control
Cell, Gene and Nucleic Therapies (Novel Modalities)
Cell Therapy Manufacturing/Analytics
Gene Therapy Manufacturing/Analytics
Nucleic Acid Manufacturing/Analytics
mRNA Vaccine Manufacturing/Analytics
Regulations and Standards
Manufacturing
Digital Biomanufacturing and Industry 4.0 Concepts
Process Characterization, Modeling & Control
Agile and Mobile Manufacturing
Integrated/Continuous Production
This year’s Bioprocessing Virtual Event features several expert speakers, including Dr. Stephen Angeloni, Senior Field Application Scientist, Luminex Corporation; Dr. Basar Bilgicer, Professor, Department of Chemical and Biomolecular Engineering, Department of Chemistry and Biochemistry, Mike and Josie Harper Cancer Research Institute, Berthiaume Institute for Precision Health, Center for Rare & Neglected Diseases, University of Notre Dame; and Roumen Bogoev, Head of Segment Marketing, GenScript USA Inc.; to name a few.
To learn more about the event, speakers, and how to participate, click here.
Even though the event is live for only one day, it will remain open to the public until April 5, 2025, meaning you can share it with any colleagues who might be unable to attend on the day after the fact.
While attending this incredible event, don't forget to use the hashtag #LRBioPro to follow the conversation while connecting with other members of the Neuroscience worldwide community.
